Ozempic (GLP-1) Lawsuit — Free Case Review
No Settlement Exists — Here's What Does
Anyone quoting amounts is guessing. What's real is eligibility — see whether your diagnosis, testing, and dates qualify.
No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.
Did this happen to you — or someone you love?
Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.
Partners
Matthew T. Marin & Stefanie A. Murphy
Super Lawyers® honorees · American Association for Justice members
Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.
No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.
No Ozempic settlement exists. As of September 2026 there are no settlements, no verdicts, no settlement program, and no trial date in any GLP-1 injury lawsuit — so every specific dollar figure you have seen advertised is a projection, not a result.
Why you’re seeing six- and seven-figure ads anyway
Legal marketing pages project numbers by borrowing from past drug litigations. Those comparisons can be constructed honestly or dishonestly, but either way they share one property: they are guesses about cases that have not resolved, made before the court has even decided which expert evidence a jury would be allowed to hear. That decision — the September 14–18, 2026 hearing in MDL 3094 — will do more to shape any eventual stomach-injury settlement than anything a marketing page says today. A firm that quotes you a number before then is telling you about its advertising strategy, not your case.
What will actually determine compensation — if these cases resolve
Mass-tort resolutions, when they happen, are typically tiered by individual facts.
Based on how comparable pharmaceutical litigations have been structured, the factors most likely to matter here include: the injury itself and its permanence (a resolved obstruction is different from a feeding tube; partial vision loss is different from legal blindness in one eye); the strength of the medical documentation (the court already requires an objective gastric emptying study for gastroparesis claims); hospitalizations and medical bills; lost work and earning capacity; age and life impact; and the strength of the causation science for each injury track at the time of resolution.
Some cases in every mass tort resolve at zero — that is not a scare line, it is the honest floor, and it is why no percentage or average can be promised in advance.
The two tracks will not necessarily resolve together
The stomach-injury cases (MDL 3094) and the NAION vision-loss cases (MDL 3163) are separate proceedings at very different stages. It is entirely possible for one track to resolve and the other to fail, or for their timelines to differ by years. Anyone quoting one “Ozempic settlement” number across both injuries is flattening a distinction the courts themselves drew.
How to use this page
Bookmark it. When a settlement or verdict actually exists, this page and our verdicts & settlements ledger will report it with docket citations, and our litigation tracker follows the hearings that will get us there. Until then, the useful question isn’t “how much” — it’s “do I have a documentable claim at all?” That one we can help answer now, for free.
Free, confidential case review. Marin & Murphy is currently accepting Ozempic (GLP-1) stomach-injury and NAION vision-loss cases. No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted. Marin & Murphy is licensed in Rhode Island, Connecticut, Massachusetts, and South Carolina; matters elsewhere may be referred to lawyers licensed in your state.
Start your free case review or call (888) 348-2735 — answered 24/7.
See if you qualify
A few quick questions about which GLP-1 medication you took, your diagnosis and testing, and your treatment. This is the initial intake screening, not a full case review. Most people finish in about two minutes.
- 🔒 Confidential
- No obligation
- ⏱ ~2 minutes
Marin & Murphy Law Firm · Free & confidential · Stop messages anytime
Common questions
Has anyone received money from an Ozempic lawsuit?
No. As of September 2026, no plaintiff has received a settlement or verdict in any GLP-1 injury lawsuit. Both MDLs are in pretrial proceedings.
When will the Ozempic lawsuits settle?
Nobody knows, and no honest answer pretends to. The nearest events that could move the timeline are the September 2026 expert-evidence hearing in the stomach-injury MDL and the early motion practice now underway in the NAION MDL. Comparable drug litigations have taken three to seven years from consolidation to resolution — and some never resolve favorably at all.
Will filing early get me more money?
Filing has no queue-jumping prize, but waiting has real risks: state filing deadlines run, records get harder to collect, and memories fade. The right reason to act now is preserving your claim and your evidence, not a payout schedule.
What percentage would the lawyers take?
Marin & Murphy handles these cases on a contingency basis — no fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted. The specific terms are set out in writing before you sign anything, and you owe nothing for a case review.
Sources
- JPML Pending MDL Statistics Report (Sept. 2026) — MDL 3094; MDL 3163
- MDL 3094 docket, E.D. Pa. — Rule 702 hearing schedule (Sept. 14–18, 2026)
- MDL 3094 Doc. 468 (Aug. 15, 2025) — gastric-emptying-study requirement
No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone’s injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.
Attorney Advertising.
This page is attorney advertising and is for informational purposes only; it is not legal or medical advice. Prior results do not guarantee a similar outcome. Contacting the firm does not create an attorney-client relationship.
More on the Ozempic (GLP-1) litigation
- Ozempic lawsuit overview (hub)
- Ozempic lawyer: what an attorney does, costs, how to choose
- How to join the Ozempic lawsuit
- Ozempic lawsuit payout per person
- Ozempic & GLP-1 lawsuit tracker
- Verdicts & settlements ledger
- The September 2026 expert hearing
- MDL 3163: the vision-loss court
- Stomach paralysis (gastroparesis) claims
- NAION vision-loss claims
- The gastric emptying study, explained
- How compensation works
- Is it too late to file?
- For spouses & caregivers